Civita Care Center At Newington
Inspection Findings
F-Tag F0658
F 0658 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few
FORM CMS-2567 (02/99) Previous Versions Obsolete
was poured by the nurse to ensure the medications are consumed as ordered. 2. Resident #178 was admitted to the facility from an acute care hospital on 6/25/25 with diagnoses that included depression, and anxiety disorder.The nursing admission assessment dated [DATE REDACTED] identified Resident #178 was alert and oriented to person, place and time, had no impairments to upper or lower extremities and utilized a wheelchair for mobility.The care plan dated 6/26/25 identified Resident #178 required assistance with dressing, hygiene, eating, bathing and toileting with interventions directed to provide set-up, supervision and or assistance with activities of daily living (ADLs) as needed. The care plan further identified Resident #178 received psychotropic medication related to anxiety and depression. The physician order dated 6/26/25 directed to administer Alprazolam extended release (ER) (24hr) 1milligram (mg) tablet once daily at 9:00 AM for anxiety disorder.Review of the electronic medication administration record (eMAR) for the month of June 2025 identified Alprazolam ER 1mg tablet was administered to Resident #178 on 6/26/25 at 10:12 AM by LPN #5.Review of Resident #178's controlled disposition record for Alprazolam ER 1mg tablet identified that the medication was delivered to the facility on 6/27/25. Review of the facility's emergency medication supply inventory list failed to identify the facility stocked Alprazolam ER 1mg tablet as part of their emergency supply of medications. Review of the controlled medication transactions per patient for the period of 6/1/25 through 6/26/25 facility failed to identify any residents with an order for Alprazolam ER 1mg tablets.Interview with the Charge Nurse (LPN #5) on 8/19/25 at 11:20 AM after a review of the controlled disposition record for the Alprazolam ER 1 mg for Resident #178, she identified that the medication arrived to the facility on 6/27/25. She acknowledged that she signed the medication administration record on 6/26/25 indicating that the medication had been administered to Resident #178, but she could not identify where she obtained the medication or if the medication was actually administered. In addition, LPN #5 noted that when a medication is unavailable, she would normally notify the nursing supervisor and if the resident needed the medication emergently, she identified that she would borrow the medication from another resident. Interview with the Pharmacist (Pharmacist #3) from the pharmacy that supplies the medications to the facility on 8/19/25 at 12:05 PM identified the pharmacy received a prescription for Alprazolam ER 1mg tablet once daily on 6/26/25 and the medication was delivered to the facility on 6/27/25. Interview with the DNS on 8/19/25 at 2:44 PM identified that when a resident's medications are not available, the nurses should not borrow from another resident. She identified that if medication is unavailable, the charge nurse should notify the supervisor, the pharmacy should be contacted, the emergency supply of the medication should be checked, and the physician should be notified. Interview with the DNS on 8/20/25 at 8:30 AM identified she reviewed the controlled disposition reports for the facility for the time period of 6/1/25 through 6/26/25 and was unable to identify a resident in the facility on Alprazolam ER 1mg tablet at the time LPN #5 signed the eMAR indicating that the medication was administered to Resident #178 as ordered. She also identified that that medication was not a medication that the facility kept as part of their emergency supply of medications, thus LPN #5 could not have administered the medication and the eMAR documentation was incorrect. Review of the Medication Shortage/Unavailable Medications identified when medications are not received or are unavailable for the customers, the licensed nurse will urgently initiate action in cooperation with the attending physician and pharmacy provider.
Event ID:
Facility ID:
If continuation sheet
CIVITA CARE CENTER AT NEWINGTON in NEWINGTON, CT inspection on recent inspection.
Found 0 violation(s). Severity: Standard violations. Status: 0 corrected, 0 pending.
Frequently Asked Questions
- What is an F-tag violation?
- F-tags are federal deficiency codes used by CMS to categorize nursing home violations. Each F-tag corresponds to a specific federal regulation (42 CFR Part 483). For example, F607 relates to abuse prevention policies, F880 relates to infection control.
- Were these violations corrected?
- Facilities must submit plans of correction and implement changes within required timeframes. CMS conducts follow-up inspections to verify corrections. Check the inspection report for specific correction dates and follow-up verification status.
- How often do nursing home inspections happen?
- CMS conducts unannounced inspections of all Medicare/Medicaid-certified nursing homes at least once per year. Additional inspections may occur based on complaints, facility-reported incidents, or follow-up to verify previous violations were corrected.
- What should families do about these violations?
- Families should: (1) Review the full inspection report for details, (2) Ask facility administration about specific corrective actions taken, (3) Check if this represents a pattern by reviewing prior inspections, (4) Compare with other facilities in NEWINGTON, CT, (5) Report new concerns to state authorities.
- Where can I see the full inspection report?
- Complete inspection reports are available on Medicare.gov's Care Compare website (www.medicare.gov/care-compare). You can also request copies directly from CIVITA CARE CENTER AT NEWINGTON or from the state Department of Health. Reports include deficiency codes, facility responses, and correction timelines.